MAP4K3 and triple-negative breast carcinoma: Liang et al. reported that miR-206 inhibited triple-negative breast cancer cell invasion and angiogenesis through downregulating vascular endothelial growth factor (VEGF), mitogen-activated protein kinase 3(MAPK3), and SOX9 expression levels [38].